| Autor: |
Van Dyck M; Laboratory of Cell Biology and Histology, University of Antwerp, CDE, Antwerp, Belgium.; Janssen Research and Development, Neuroscience Therapeutic Area, Beerse, Belgium., Mishra RK; Janssen Research and Development, Neuroscience Therapeutic Area, Beerse, Belgium.; Present address: iOligos Technologies Private Limited, 1703, CB2, Supertech Capetown, Sector‑74, 201301, Noida, India., Pestana F; Janssen Research and Development, Neuroscience Therapeutic Area, Beerse, Belgium., Verstraelen P; Laboratory of Cell Biology and Histology, University of Antwerp, CDE, Antwerp, Belgium., Lavreysen H; Janssen Research and Development, Neuroscience Therapeutic Area, Beerse, Belgium., Pita-Almenar JD; Janssen Research and Development, Neuroscience Therapeutic Area, Beerse, Belgium., Kashikar ND; Janssen Research and Development, Neuroscience Therapeutic Area, Beerse, Belgium. nachiket.kashikar@resolve-biosciences.com.; Present address: Resolve BioSciences GmbH, Creative Campus Monheim Gebäude A03, Alfred‑Nobel‑Strasse 10, 40789 Monheim am Rhein, Germany. nachiket.kashikar@resolve-biosciences.com., De Vos WH; Laboratory of Cell Biology and Histology, University of Antwerp, CDE, Antwerp, Belgium. Winnok.DeVos@uantwerpen.be. |
Full text from SpringerLink